Peng Yu
About
Peng Yu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery.
According to data from OpenAlex, Peng Yu has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 27 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in Peng Yu's work include Cardiovascular Function and Risk Factors (16 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). Peng Yu is often cited by papers focused on Cardiovascular Function and Risk Factors (16 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). Peng Yu collaborates with scholars based in China, United States and Hong Kong. Peng Yu's co-authors include Jianyong Ma, Wengen Zhu, Xiao Liu, Jing Zhang, Menglu Liu, Ziqi Tan, Yujie Zhao, Huilei Zhao, Le Shen and Jingfeng Wang and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.
In The Last Decade
Peng Yu
92 papers receiving 2.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Peng Yu China | 25 | 669 | 497 | 313 | 292 | 252 | 98 | 2.0k | ||
| Anil Bhanudas Gaikwad India | 29 | 908 1.4× | 372 0.7× | 224 0.7× | 169 0.6× | 257 1.0× | 110 | 2.3k | ||
| Di Xie China | 28 | 555 0.8× | 670 1.3× | 212 0.7× | 166 0.6× | 250 1.0× | 84 | 2.8k | ||
| Zonggui Wu China | 21 | 625 0.9× | 435 0.9× | 174 0.6× | 116 0.4× | 203 0.8× | 67 | 1.9k | ||
| Seok Joon Shin South Korea | 28 | 738 1.1× | 332 0.7× | 335 1.1× | 178 0.6× | 391 1.6× | 89 | 2.6k | ||
| Yugang Dong China | 27 | 988 1.5× | 1.1k 2.2× | 326 1.0× | 120 0.4× | 448 1.8× | 177 | 2.7k | ||
| Dong Cheol Han China | 15 | 587 0.9× | 353 0.7× | 451 1.4× | 126 0.4× | 313 1.2× | 33 | 2.3k | ||
| Won Kim South Korea | 28 | 972 1.5× | 205 0.4× | 286 0.9× | 378 1.3× | 294 1.2× | 79 | 2.7k | ||
| Jianyong Ma United States | 22 | 429 0.6× | 656 1.3× | 284 0.9× | 126 0.4× | 184 0.7× | 86 | 1.8k | ||
| Xulei Tang China | 21 | 689 1.0× | 257 0.5× | 238 0.8× | 430 1.5× | 237 0.9× | 85 | 1.8k | ||
| Kum Hyun Han South Korea | 27 | 545 0.8× | 336 0.7× | 315 1.0× | 105 0.4× | 315 1.3× | 50 | 2.0k |
Countries citing papers authored by Peng Yu
Since
Specialization
Citations
This map shows the geographic impact of Peng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yu more than expected).
Fields of papers citing papers by Peng Yu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Peng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yu. The network helps show where Peng Yu may publish in the future.
Co-authorship network of co-authors of Peng Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Yu. A scholar is included among the top collaborators of Peng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Yu. Peng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zhang, Jun, Ling Lin, Yucheng Wu, et al.. (2025). Prognostic value of FIB-4 and NFS for cardiovascular events in patients with and without NAFLD. BMC Public Health. 25(1). 2747–2747.
2.
Zhang, Deju, et al.. (2025). Role of Exosomes in Cardiovascular Disease: A Key Regulator of Intercellular Communication in Cardiomyocytes. ACS Omega. 10(18). 18145–18169.
3.
Peng, Nan‐Jing, Xiyu Zhang, Wenli Gu, et al.. (2025). The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study. Cardiovascular Diabetology. 24(1). 65–65.
4.
Li, Yaqi, Yixuan Chen, Peng Yu, et al.. (2024). Mild therapeutic hypothermic protection activates the PI3K/AKT signaling pathway to inhibit TRPM7 and suppress ferroptosis induced by myocardial ischemia‑reperfusion injury. Molecular Medicine Reports. 30(6).
5.
Ye, Zhenfeng, Jing Zhang, Zhou Xu, et al.. (2024). Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome. Human Cell. 37(4). 959–971.
6.
Zhao, Huilei, Menglu Liu, Weichun Lin, et al.. (2023). Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Drugs. 83(14). 1293–1307.
7.
Zhu, Zhongyu, Peng Yu, Yuying Wu, et al.. (2023). Sex Specific Global Burden of Osteoporosis in 204 Countries and Territories, from 1990 to 2030: An Age-Period-Cohort Modeling Study. The journal of nutrition health & aging. 27(9). 767–774.
8.
Liu, Fuwei, Shaofeng Xie, Menglu Liu, et al.. (2023). Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis. Cardiovascular Diabetology. 22(1). 111–111.
9.
Zhao, Huilei, Ziqi Tan, Menglu Liu, et al.. (2023). Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 12(11). e026270–e026270.
10.
Zhang, Deju, et al.. (2023). Replacing animal proteins with plant proteins: Is this a way to improve quality and functional properties of hybrid cheeses and cheese analogs?. Comprehensive Reviews in Food Science and Food Safety. 23(1). e13262–e13262.
11.
Liu, Menglu, Ziqi Tan, Shan Huang, et al.. (2022). Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–11.
12.
Zhang, Jing, Hongguang Sheng, Xiaoyi Tang, et al.. (2022). Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19. Frontiers in Cellular and Infection Microbiology. 12. 935280–935280.
13.
Zhang, Jing, Xiaozhong Li, Yiwen Zhou, et al.. (2022). The Emerging Role of Noncoding RNA Regulation of the Ferroptosis in Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. 2022(1). 3595745–3595745.
14.
Zhao, Huilei, Wen Shao, Jing Zhang, et al.. (2021). Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysis. Research Square.
15.
Chen, Jie, Ping Yuan, Jianyong Ma, et al.. (2021). Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs. Nutrition Journal. 20(1). 89–89.
16.
Wang, Mengxi, Weixin Sun, Jie Han, et al.. (2021). Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 12. 751050–751050.
17.
Zhang, Qian, Weixin Sun, Jie Han, et al.. (2020). The circular RNA hsa_circ_0007623 acts as a sponge of microRNA-297 and promotes cardiac repair. Biochemical and Biophysical Research Communications. 523(4). 993–1000.
18.
Zhang, Jing, Fan Xiao, Lieliang Zhang, et al.. (2018). Alpha-Lipoic Acid Preconditioning and Ischaemic Postconditioning Synergistically Protect Rats from Cerebral Injury Induced by Ischemia and Reperfusion Partly via Inhibition TLR4/MyD88/ NF-κB Signaling Pathway. Cellular Physiology and Biochemistry. 51(3). 1448–1460.
19.
Zhang, Jiru, Jing Zhang, Peng Yu, et al.. (2017). Remote Ischaemic Preconditioning and Sevoflurane Postconditioning Synergistically Protect Rats from Myocardial Injury Induced by Ischemia and Reperfusion Partly via Inhibition TLR4/MyD88/NF-κB Signaling Pathway. Cellular Physiology and Biochemistry. 41(1). 22–32.
20.
Zhang, Jing, Shuchun Yu, Qin Liu, et al.. (2014). Sevoflurane Postconditioning Protects Rat Hearts against Ischemia-Reperfusion Injury via the Activation of PI3K/AKT/mTOR Signaling. Scientific Reports. 4(1). 7317–7317.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Anil Bhanudas Gaikwad Breakdown of academic impact, for papers by Di Xie Breakdown of academic impact, for papers by Zonggui Wu Breakdown of academic impact, for papers by Seok Joon Shin Breakdown of academic impact, for papers by Yugang Dong Breakdown of academic impact, for papers by Dong Cheol Han Breakdown of academic impact, for papers by Won Kim Breakdown of academic impact, for papers by Jianyong Ma Breakdown of academic impact, for papers by Xulei Tang Breakdown of academic impact, for papers by Kum Hyun Han